Boston Trust Walden’s Labcorp LH Stock Holding History

Boston Trust Walden’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-900	Closed	-$258K	–	394
2025 Q3	$258K	Hold	900	–	–	﹤0.01%	372
2025 Q2	$236K	Sell	900 -31,689	-97%	-$7.72M	﹤0.01%	360
2025 Q1	$7.58M	Sell	32,589 -330	-1%	-$80.1K	0.06%	218
2024 Q4	$7.55M	Buy	32,919 +24	+0.1%	+$5.51K	0.05%	217
2024 Q3	$7.35M	Buy	32,895 +149	+0.5%	+$32.7K	0.05%	218
2024 Q2	$6.66M	Buy	32,746 +1,414	+5%	+$288K	0.05%	218
2024 Q1	$6.84M	Buy	31,332 +8,271	+36%	+$1.82M	0.05%	220
2023 Q4	$5.24M	Sell	23,061 -82	-0.4%	-$17.2K	0.04%	222
2023 Q3	$4.65M	Sell	23,143 -3,612	-14%	-$762K	0.04%	225
2023 Q2	$5.55M	Buy	26,755 +885	+3%	+$172K	0.05%	225
2023 Q1	$5.1M	Sell	25,870 -297	-1%	-$61.1K	0.04%	227
2022 Q4	$5.29M	Sell	26,167 -40	-0.2%	-$7.82K	0.05%	231
2022 Q3	$4.61M	Buy	26,207 +209	+0.8%	+$42.8K	0.05%	231
2022 Q2	$5.24M	Sell	25,998 -1,152	-4%	-$246K	0.05%	229
2022 Q1	$6.15M	Buy	27,150 +855	+3%	+$201K	0.05%	229
2021 Q4	$7.1M	Sell	26,295 -931	-3%	-$230K	0.06%	227
2021 Q3	$6.58M	Buy	27,226 +99	+0.4%	+$24.9K	0.06%	222
2021 Q2	$6.43M	Buy	27,127 +10,918	+67%	+$2.49M	0.06%	225
2021 Q1	$3.55M	Sell	16,209 -669	-4%	-$134K	0.03%	244
2020 Q4	$2.95M	Sell	16,878 -140	-0.8%	-$24.2K	0.03%	250
2020 Q3	$2.75M	Sell	17,018 -902	-5%	-$143K	0.03%	257
2020 Q2	$2.56M	Buy	17,920 +990	+6%	+$137K	0.03%	257
2020 Q1	$1.84M	Sell	16,930 -29	-0.2%	-$4.18K	0.03%	260
2019 Q4	$2.46M	Buy	16,959 +4,365	+35%	+$630K	0.03%	259
2019 Q3	$1.82M	Buy	12,594 +1,571	+14%	+$229K	0.02%	269
2019 Q2	$1.64M	Buy	11,023 +175	+2%	+$24.4K	0.02%	280
2019 Q1	$1.43M	Sell	10,848 -1,164	-10%	-$143K	0.02%	286
2018 Q4	$1.3M	Buy	12,012 +4,772	+66%	+$639K	0.02%	287
2018 Q3	$1.08M	Sell	7,240 -291	-4%	-$44.3K	0.01%	300
2018 Q2	$1.16M	Sell	7,531 -2,305	-23%	-$348K	0.02%	298
2018 Q1	$1.37M	Hold	9,836	–	–	0.02%	289
2017 Q4	$1.35M	Sell	9,836 -15,894	-62%	-$2.1M	0.02%	292
2017 Q3	$3.34M	Buy	25,730 +3,911	+18%	+$522K	0.05%	243
2017 Q2	$2.89M	Sell	21,819 -192	-0.9%	-$23.5K	0.05%	251
2017 Q1	$2.71M	Sell	22,011 -233	-1%	-$27.6K	0.04%	249
2016 Q4	$2.45M	Buy	22,244 +163	+0.7%	+$18.1K	0.04%	254
2016 Q3	$2.61M	Hold	22,081	–	–	0.04%	247
2016 Q2	$2.47M	Sell	22,081 -233	-1%	-$25.1K	0.04%	253
2016 Q1	$2.25M	Sell	22,314 -233	-1%	-$22.3K	0.04%	258
2015 Q4	$2.4M	Buy	22,547 +1,467	+7%	+$151K	0.04%	251
2015 Q3	$1.97M	Buy	21,080 +885	+4%	+$91.5K	0.03%	261
2015 Q2	$2.1M	Buy	20,195 +4,597	+29%	+$479K	0.03%	255
2015 Q1	$1.69M	Buy	15,598 +582	+4%	+$59.9K	0.03%	257
2014 Q4	$1.39M	Hold	15,016	–	–	0.02%	271
2014 Q3	$1.31M	Sell	15,016 -116	-0.8%	-$10.5K	0.02%	265
2014 Q2	$1.33M	Hold	15,132	–	–	0.02%	261
2014 Q1	$1.28M	Buy	15,132 +2,735	+22%	+$218K	0.02%	247
2013 Q4	$973K	Sell	12,397 -262	-2%	-$22.3K	0.01%	265
2013 Q3	$1.08M	Sell	12,659 -116	-0.9%	-$9.77K	0.02%	247
2013 Q2	$1.1M	Buy	+12,775	New	+$1.06M	0.02%	238

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Trust Walden's LH Position: Q4 2025 in Review

Boston Trust Walden sold out of Labcorp (LH) in Q4 2025, closing a stake of 900 shares — an estimated $258K sold.

Boston Trust Walden first reported a position in LH in Q2 2013 and held it in 50 quarters. The position peaked at $7.58M in Q1 2025. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Boston Trust Walden reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Boston Trust Walden sold 900 Labcorp shares in Q4 2025, an estimated $258K.
Boston Trust Walden first reported a position in Labcorp in Q2 2013 and held it in 50 quarters.
Boston Trust Walden's Labcorp position peaked at $7.58M in Q1 2025.
1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Boston Trust Walden's 13F filing for Q4 2025, filed 28 Jan 2026.